Kenneth Y. Tsai, MD, PhD, FAAD
SESSIONS
S045 Updates in Cutaneous Oncology
Mar 10, 2024
•
1:00 PM - 4:00 PM
•
Room 24C
S061 The 2024 Debates: Controversies in Dermatology
Mar 11, 2024
•
1:00 PM - 4:00 PM
•
Room 31B
DISCLOSURES
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);